{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:47:28Z","timestamp":1773236848034,"version":"3.50.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1093\/cvr\/cvt011","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T01:02:05Z","timestamp":1358902925000},"page":"56-63","source":"Crossref","is-referenced-by-count":25,"title":["FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters"],"prefix":"10.1093","volume":"98","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Nachtigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissavet","family":"Kardami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Cattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"key\n\t\t\t\t20170523020416_CVT011C1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/mi.5.3.6","article-title":"The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine","volume":"5","author":"Peng","year":"2005","journal-title":"Mol Interv"},{"key":"key\n\t\t\t\t20170523020416_CVT011C3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0301-4622(98)00150-1","article-title":"Deciphering the fluorescence signature of daunomycin and doxorubicin","volume":"73","author":"Karukstis","year":"1998","journal-title":"Biophys Chem"},{"key":"key\n\t\t\t\t20170523020416_CVT011C4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0008-6363(02)00708-3","article-title":"Biological activities of fibroblast growth factor-2 in the adult myocardium","volume":"57","author":"Detillieux","year":"2003","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1139\/y04-126","article-title":"Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2","volume":"82","author":"Detillieux","year":"2004","journal-title":"Can J Physiol Pharmacol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","article-title":"Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function","volume":"171","author":"Virag","year":"2007","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cardiores.2004.01.009","article-title":"Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion","volume":"62","author":"Jiang","year":"2004","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10741-007-9027-0","article-title":"Fibroblast growth factor-2 and cardioprotection","volume":"12","author":"Kardami","year":"2007","journal-title":"Heart Fail Rev"},{"key":"key\n\t\t\t\t20170523020416_CVT011C9","doi-asserted-by":"crossref","first-page":"H1071","DOI":"10.1152\/ajpheart.00290.2001","article-title":"Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C","volume":"282","author":"Jiang","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C10","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1006\/jmcc.1998.0832","article-title":"FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C","volume":"30","author":"Padua","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.yjmcc.2011.07.013","article-title":"PKC-delta and PKC-epsilon: Foes of the same family or strangers?","volume":"51","author":"Duquesnes","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cardiores.2004.01.032","article-title":"Transcriptional regulation of FGF-2 gene expression in cardiac myocytes","volume":"62","author":"Jimenez","year":"2004","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C13","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1161\/01.CIR.0000105723.91637.1C","article-title":"Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia","volume":"108","author":"House","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170523020416_CVT011C14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1368-7646(03)00023-2","article-title":"Positive and negative regulation of cellular sensitivity to anti-cancer drugs by FGF-2","volume":"6","author":"Coleman","year":"2003","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170523020416_CVT011C15","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"key\n\t\t\t\t20170523020416_CVT011C16","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-07-0148","article-title":"Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein","volume":"6","author":"Katayama","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20170523020416_CVT011C17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0972-2327.53076","article-title":"Role of multidrug transporters in neurotherapeutics","volume":"12","author":"Jose","year":"2009","journal-title":"Ann Indian Acad Neurol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.2174\/092986709788186228","article-title":"New developments in anthracycline-induced cardiotoxicity","volume":"16","author":"Mordente","year":"2009","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20170523020416_CVT011C19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/pr.58.2.7","article-title":"The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart","volume":"58","author":"Couture","year":"2006","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20170523020416_CVT011C20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1124\/mol.108.052209","article-title":"Mrp1 localization and function in cardiac mitochondria after doxorubicin","volume":"75","author":"Jungsuwadee","year":"2009","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C21","first-page":"3901","article-title":"Structural and functional effects of adriamycin on cardiac cells in vitro","volume":"40","author":"Lampidis","year":"1980","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.niox.2003.12.001","article-title":"Prevention of doxorubicin-induced damage to rat heart myocytes by arginine analog nitric oxide synthase inhibitors and their enantiomers","volume":"9","author":"Barnabe","year":"2003","journal-title":"Nitric Oxide"},{"key":"key\n\t\t\t\t20170523020416_CVT011C23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-4800(88)90067-6","article-title":"Lactate dehydrogenase activity in cultured neonatal rat heart cells exposed to doxorubicin","volume":"48","author":"Howard","year":"1988","journal-title":"Exp Mol Pathol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C24","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1253\/circj.71.1815","article-title":"Edaravone, a potent free radical scavenger, prevents anthracycline-induced myocardial cell death","volume":"71","author":"Ikegami","year":"2007","journal-title":"Circ J"},{"key":"key\n\t\t\t\t20170523020416_CVT011C25","first-page":"416","article-title":"Anthracycline effects on actin and actin-containing thin filaments in cultured neonatal rat myocardial cells","volume":"54","author":"Lewis","year":"1986","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t20170523020416_CVT011C26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/dna.2007.0689","article-title":"A myocyte enhancer factor 2 (MEF2) site located in a hypersensitive region of the FGF16 gene locus is required for preferential promoter activity in neonatal cardiac myocytes","volume":"27","author":"Sofronescu","year":"2008","journal-title":"DNA Cell Biol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C27","doi-asserted-by":"crossref","first-page":"C1242","DOI":"10.1152\/ajpcell.00529.2007","article-title":"FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development","volume":"294","author":"Lu","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvq025","article-title":"FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart","volume":"87","author":"Sofronescu","year":"2010","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12012-012-9183-x","article-title":"The Dual-targeted HER1\/HER2 tyrosine kinase inhibitor lapatinib strongly potentiates the cardiac myocyte-damaging effects of doxorubicin","volume":"13","author":"Hasinoff","year":"2013","journal-title":"Cardiovasc Toxicol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1016196514217","article-title":"Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE","volume":"19","author":"Tang","year":"2002","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0887-2333(99)00087-9","article-title":"Effect of PSC 833, verapamil and amiodarone on adriamycin toxicity in cultured rat cardiomyocytes","volume":"14","author":"Estevez","year":"2000","journal-title":"Toxicol In Vitro"},{"key":"key\n\t\t\t\t20170523020416_CVT011C32","first-page":"4186","article-title":"Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration","volume":"6","author":"Stewart","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C33","doi-asserted-by":"crossref","first-page":"e31393","DOI":"10.1371\/journal.pone.0031393","article-title":"Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor","volume":"7","author":"Tarasenko","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170523020416_CVT011C34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-009-0051-8","article-title":"Cardiomyocyte death in doxorubicin-induced cardiotoxicity","volume":"57","author":"Zhang","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key\n\t\t\t\t20170523020416_CVT011C35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1006\/jmcc.1993.1162","article-title":"Protection by cyclosporin A of ischemia\/reperfusion-induced damage in isolated rat hearts","volume":"25","author":"Griffiths","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.107.127704","article-title":"Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells","volume":"324","author":"Shen","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170523020416_CVT011C37","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1073\/pnas.140210697","article-title":"Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs","volume":"97","author":"Song","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170523020416_CVT011C38","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-06-3648","article-title":"Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1","volume":"67","author":"Alavi","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170523020416_CVT011C39","first-page":"324","article-title":"Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin","volume":"57","author":"Coleman","year":"2000","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/dmd.108.023721","article-title":"Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice","volume":"37","author":"Cui","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t20170523020416_CVT011C41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0006-2952(02)01268-6","article-title":"Chemosensitization by fibroblast growth factor-2 is not dependent upon proliferation, S-phase accumulation, or p53 status","volume":"64","author":"Coleman","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170523020416_CVT011C42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000076466","article-title":"Modulation of multidrug-resistance-associated P-glycoprotein in human U-87 MG and HUV-ECC cells with antisense oligodeoxynucleotides to MDR1 mRNA","volume":"71","author":"Rittierodt","year":"2004","journal-title":"Pathobiology"},{"key":"key\n\t\t\t\t20170523020416_CVT011C43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cvr\/cvp142","article-title":"Phosphorylation of connexin-43 at serine 262 promotes a cardiac injury-resistant state","volume":"83","author":"Srisakuldee","year":"2009","journal-title":"Cardiovasc Res"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/98\/1\/56\/17394160\/cvt011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T16:28:28Z","timestamp":1503419308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-lookup\/doi\/10.1093\/cvr\/cvt011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,22]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvt011","relation":{},"ISSN":["1755-3245","0008-6363"],"issn-type":[{"value":"1755-3245","type":"electronic"},{"value":"0008-6363","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}